Bank of New York Mellon »

Kiniksa Pharmaceuticals shares owned by Bank of New York Mellon

Quarter-by-quarter ownership of Kiniksa Pharmaceuticals (KNSA) shares owned by Bank of New York Mellon from 13F filings

Historical chart of Bank of New York Mellon investment in Kiniksa Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Kiniksa Pharmaceuticals held by Bank of New York Mellon consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kiniksa Pharmaceuticals by Bank of New York Mellon

Quarter filed Position value Share count Share price at filing
2024-03-31 $2.2M 113k 19.73
2023-12-31 $2.3M 134k 17.54
2023-09-30 $2.5M 147k 17.37
2023-06-30 $1.8M 129k 14.08
2023-03-31 $1.4M 128k 10.76
2022-12-31 $1.9M 127k 14.98
2022-09-30 $1.7M 126k 13.33
2022-06-30 $1.2M 121k 9.71
2022-03-31 $1.4M 137k 9.95
2021-12-31 $1.8M 134k 13.33
2021-09-30 $1.5M 135k 11.38
2021-06-30 $1.8M 131k 13.95
2021-03-31 $2.5M 134k 18.52
2020-12-31 $2.4M 137k 17.67
2020-09-30 $1.4M 91k 15.31
2020-06-30 $2.0M 78k 25.47
2020-03-31 $751k 48k 15.57
2019-12-31 $514k 46k 11.12
2019-09-30 $444k 52k 8.50
2019-06-30 $764k 56k 13.56
2019-03-31 $853k 47k 18.16
2018-12-31 $578k 21k 28.10
2018-09-30 $433k 17k 25.37